[Back-ground factors which affect the outcome of steroid withdrawal therapy in patients with chronic type B hepatitis--statistical evaluation of the importance of the mode of HBV transmission].
Tokita
H
H
Shimizu
M
M
Takahashi
Y
Y
Tanaka
H
H
Yasuda
M
M
Kojima
M
M
Adachi
N
N
Yoshida
H
H
D000293:Adolescent; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006509:Hepatitis B / Q000188:drug therapy* / Q000635:transmission; D006514:Hepatitis B Surface Antigens / Q000032:analysis*; D006513:Hepatitis B e Antigens / Q000032:analysis*; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage*
D006514:Hepatitis B Surface Antigens; D006513:Hepatitis B e Antigens; D011239:Prednisolone; D000410:Alanine Transaminase